Research Interests

• Drug Immune Osteogenesis and Antibacterial:To explore the new mechanism of miR-29 mediated dialogue between endothelial cells and osteoblasts, and provide new ideas and methods for the treatment of bone metabolic diseases.

• Monitoring and management system of clinical drug treatment related problems based on “PCNE classification system”: Complete the Chinese translation of "PCNE Drug Related Problems Classification V8.02" and the homogenization training of relevant operators, to provide data support for the application of PCNE in China